Last year healthcare providers remotely monitored about 308,000 patients worldwide for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions, according to a recent report from InMedica. By 2017 that number should spike to 1.8...
Posted to
News
by
mobihealthnews
on
Tue, Jan 22 2013
Filed under:
Filed under: Uncategorized, COPD, Congestive Heart Failure, diabetes, Mental health, remote patient monitoring, chronic condition management, InMedica, IHS, mobile health metrics, hypertension, Berg Insight, IMS Research, digital health metrics
MobiHealthNews covered health coaching platform company Healthrageous’s $6.5 million second round funding last month, but the company just announced that the final investor in that round was the Partners Innovation Fund, a division of Partners HealthCare. Partners is the parent company of the Center...
Posted to
News
by
mobihealthnews
on
Mon, Nov 26 2012
Filed under:
Filed under: Uncategorized, Partners Healthcare, Healthrageous, Massachusetts General Hospital, Center for Connected Health, Brigham and Women's Hospital, hypertension, mobile health behavior change, blood pressure monitoring, American Heart Journal
Major medical centers have begun testing a new medical device with the promise to relieve an otherwise untreatable form of high-blood pressure.
I have written this book, more like booklet and having a hard time finding a suitable publisher in Papua New Guinea. And it has been 3 years now. So I thought, what the heck! I will just publish it on … Continue reading →
Posted to
News
by
Pacific Family Health Journal
on
Sat, Nov 12 2011
Filed under:
Filed under: health, PNG, food, Salt, cholesterol, sugar, Port Moresby, new ginea, sodium, guide, fat, diabeters, stroke, Food labels, hypertension, traditional diet png, high blood pressure
Back in December of 2009 I covered the clinical trial process that is ongoing through this procedure to basically create a cure for high blood pressure with some patients, thus eliminating the need for medications. Medtronic has now purchased this company. Minimally Invasive Surgical Procedure...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Nov 25 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, healthcare, clinical trials, Hypertension, kidney disease, High Blood Pressure, minimally invasive procedure, catheter, renal sympathetic nerve ablation, Ardian
The drug is not recommended for patients with impaired renal functions and contains a diuretic for water volume. BD PARSIPPANY, N.J., July 26 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Tribenzor (olmesartan medoxomil...
This is interesting and a deal was made here so Teva has a 180 day exclusive. On one hand we have Teva in court with Merck over Singulair and on the other hand here, they get a deal. Teva is probably the most aggressive pharma company today with challenging patents. Merck and Singulair –...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Apr 7 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Hypertension, Generic Drugs, Merck, Patents, Teva, Intellutual property, Cozaar, Hyzaar
This is a minimally invasive procedure done via a catheter. There is no device implanted. The company also has a page to find out more about the clinical trials, focusing on patients with resistant hypertension and kidney disease and they are actively recruiting medical centers for participation...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Dec 28 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, clinical trials, Hypertension, kidney disease, High Blood Pressure, minimally invasive procedure, catheter, renal sympathetic nerve ablation, Ardian